High Blood Pressure Cure: New Treatment Hopeful
- A new, less invasive treatment called Targeted Thermal Therapy (Triple T) offers hope for millions suffering from a frequently overlooked cause of hypertension.
- The research, published in *The Lancet*, indicates that triple T, or endoscopic ultrasound-guided radiofrequency ablation, could revolutionize the management of this condition.
- Primary aldosteronism affects approximately one in 20 adults with high blood pressure, yet less than 1% are diagnosed.
Millions facing high blood pressure may soon have a new treatment option. News Directory 3 reports on a groundbreaking, minimally invasive therapy called Triple T, wich targets the root cause of primary aldosteronism—a hormonal condition frequently enough missed in diagnoses. Unlike traditional surgery, Triple T utilizes radiofrequency ablation to precisely treat adrenal nodules, potentially eliminating the need for lengthy recovery times and offering the hope, in manny cases of reducing or eliminating the need for high_blood_pressure medications. This new approach shows promise for patients struggling with this condition. Learn how this innovative treatment could revolutionize the management of high blood pressure and why this secondary_keyword is important.Discover what’s next …
new Minimally Invasive Therapy Targets Root Cause of High Blood Pressure
A new, less invasive treatment called Targeted Thermal Therapy (Triple T) offers hope for millions suffering from a frequently overlooked cause of hypertension. Developed by researchers in London, Triple T addresses primary aldosteronism, a hormonal condition where small nodules on the adrenal glands produce excess aldosterone, leading to elevated blood pressure.
The research, published in *The Lancet*, indicates that triple T, or endoscopic ultrasound-guided radiofrequency ablation, could revolutionize the management of this condition. the procedure has undergone rigorous testing in the United Kingdom.
Primary aldosteronism affects approximately one in 20 adults with high blood pressure, yet less than 1% are diagnosed. The condition frequently enough resists standard blood pressure medications, increasing the risk of heart attacks, strokes, and kidney failure.
Previously, the primary treatment involved surgical removal of the adrenal gland, requiring general anesthesia, a hospital stay, and a lengthy recovery. Triple T, though, selectively destroys the problematic adrenal nodule without removing the entire gland. Advances in diagnostic scans, using molecular dyes, enable precise identification and targeting of even the smallest nodules.
the procedure uses radiofrequency or microwaves to generate heat in a needle, creating a controlled burn. Ultrasound provides real-time video guidance. A tiny camera, using both ultrasound and light, is inserted through the mouth into the stomach, allowing the endoscopist to guide the needle into the nodule. The process takes about 20 minutes and requires no incisions.
The FABULAS study (feasibility study of radiofrequency endoscopic ABlation, with ULtrasound guidance, as a non-surgical, Adrenal Sparing treatment for aldosterone-producing adenomas) tested Triple T on 28 patients with primary aldosteronism. Results showed the procedure was safe and effective, with most patients achieving normal hormone levels within six months. manny were able to discontinue blood pressure medications, and the condition did not recur.
“It is 70 years since the finding in London of the hormone aldosterone… We are now able to realize this prospect, offering 21st-century breakthroughs in diagnosis and treatment,” said